Company / R&D per Share
Savara Inc R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.39
FY2024
5-year range
$0.18 / $0.69
FY2020-FY2024
Trend
+46.9%
vs FY2023
Sector context
#181 of 208
Health Care
What the data says
Savara Inc's r&d per share of $0.39 is lower than 87% of companies in the Health Care sector (FY2024). Improved from $0.18 to $0.39 over the past 2 years.
Based on SEC 10-K filings.
0.39 in FY2024 with a 5-year CAGR of -17.9%.
Improved from $0.18 to $0.39 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -9.7%
- 5-Year CAGR
- -17.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 208This company $0.39 Sector average $28.82
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 46.9% year-over-year.
- Ranks #181 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.39 | +46.9% |
| FY2023 | $0.27 | +46.8% |
| FY2022 | $0.18 | -65.9% |
| FY2021 | $0.54 | -22.4% |
| FY2020 | $0.69 | -34.8% |
| FY2019 | $1.06 | -5.3% |
| FY2018 | $1.12 | -80.9% |
| FY2017 | $5.85 | +11605.1% |
| FY2016 | $0.05 | +84.5% |
| FY2015 | $0.03 | -85.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026